- A federal decide concluded that Walgreens Boots Alliance Inc WBA contributed to the opioid epidemic in San Francisco via its sale of prescribed drugs, and it failed to research suspicious opioid orders for almost 15 years.
- The high-quality quantity can be decided in a later trial, Reuters reported.
- U.S. District Decide Charles Breyer wrote that Walgreens’ pharmacists stuffed a number of suspicious opioid prescriptions between 2006 – 2020, with pharmacists not given time, staffing, or assets to research crimson flags correctly.
- In 2018, San Francisco sued Walgreens over the opioid epidemic within the metropolis, saying they created a “public nuisance.”
- Additionally Learn: Allergan To Finish Round 3,000 Opioid Lawsuits With Over $2B In Settlement: Report.
- A trial started in April, and all defendants besides Walgreens reached settlements with the town earlier than the court docket dominated. Walgreens stated that it was dissatisfied with the ruling and meant to attraction.
- “We by no means manufactured or marketed opioids, nor did we distribute them to the ‘tablet mills’ and web pharmacies that fueled this disaster,” Walgreens spokesman Fraser Engerman stated.
- In the same trial in Ohio counties, Walgreens and its co-defendants, CVS Well being Inc CVS and Walmart Inc WMT had been discovered accountable for contributing to the opioid epidemic. The businesses are awaiting a ruling from the Ohio court docket on the high-quality quantity.
- Worth Motion: WBA shares are down 0.25% at $39.80 premarket on the final test Thursday.
© 2022 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
